AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Obesity is a major health crisis affecting over a third of the global population. This
multifactorial disease is regulated via interoceptive neural circuits in the brain, whose …
multifactorial disease is regulated via interoceptive neural circuits in the brain, whose …
Mortality in patients with pituitary disease
M Sherlock, J Ayuk, JW Tomlinson… - Endocrine …, 2010 - academic.oup.com
Pituitary disease is associated with increased mortality predominantly due to vascular
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …
Craniopharyngiomas
N Karavitaki, S Cudlip, CBT Adams… - Endocrine …, 2006 - academic.oup.com
Craniopharyngiomas are rare, mainly sellar/parasellar, epithelial tumors diagnosed during
childhood or adult life. Histologically, two primary subtypes have been recognized …
childhood or adult life. Histologically, two primary subtypes have been recognized …
Moderate aerobic exercise training prevents the augmented hepatic glucocorticoid response induced by high-fat diet in mice
J Dassonvalle, F Díaz-Castro… - International journal of …, 2020 - mdpi.com
Glucocorticoids (GCs) are critical regulators of energy balance. Their deregulation is
associated with the development of obesity and metabolic syndrome. However, it is not …
associated with the development of obesity and metabolic syndrome. However, it is not …
Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome
U Saleem, M Khaleghi, NG Morgenthaler… - The Journal of …, 2009 - academic.oup.com
Context: Stress-mediated hypothalamic-pituitary-adrenal axis activation, regulated by
arginine vasopressin (AVP), may have a role in the pathophysiology of metabolic syndrome …
arginine vasopressin (AVP), may have a role in the pathophysiology of metabolic syndrome …
GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
F Zoicas, M Droste, B Mayr… - European journal of …, 2013 - academic.oup.com
Background Patients with hypothalamic pathology often develop morbid obesity, causing
severe metabolic alterations resulting in increased morbidity and mortality. Glucagon-like …
severe metabolic alterations resulting in increased morbidity and mortality. Glucagon-like …
Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment
RH Lustig - Frontiers in endocrinology, 2011 - frontiersin.org
Obesity is a common complication after craniopharyngioma therapy, occurring in up to 75%
of survivors. Its weight gain is unlike that of normal obesity, in that it occurs even with caloric …
of survivors. Its weight gain is unlike that of normal obesity, in that it occurs even with caloric …
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
Objective Excessive weight gain frequently occurs in patients with hypothalamic tumors and
lesions leading to hypothalamic obesity (HO). Methods Digital brain magnetic resonance …
lesions leading to hypothalamic obesity (HO). Methods Digital brain magnetic resonance …
Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma
A Bogusz, S Boekhoff, M Warmuth-Metz… - Endocrine …, 2019 - ec.bioscientifica.com
Objective Quality of life (QoL) is frequently impaired in childhood-onset craniopharyngioma
(CP) by hypothalamic syndrome. The debate, whether pretreatment hypothalamic …
(CP) by hypothalamic syndrome. The debate, whether pretreatment hypothalamic …
[HTML][HTML] Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies
Background Childhood obesity is a serious public health problem associated with the
development of several chronic diseases, such as type 2 diabetes mellitus, dyslipidemia …
development of several chronic diseases, such as type 2 diabetes mellitus, dyslipidemia …